Glyclopyramide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Glyclopyramide
Glyclopyramide.svg
Systematic (IUPAC) name
4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
Clinical data
Legal status
  • (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Registry Number 631-27-6 N
ATC code None
PubChem CID: 71793
ChemSpider 64820 N
UNII KE474IKG1W YesY
KEGG D01799 YesY
Chemical data
Formula C11H14ClN3O3S
Molecular mass 303.76 g/mol
 N (what is this?)  (verify)

Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.

It is classified as second generation.[1]

References[edit]

  1. ^ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]". Yakugaku Zasshi (in Japanese) 38 (1): 11–27. PMID 14570054.